TMCnet - World's Largest Communications and Technology Community

TMCNet:  Market Research: MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

[December 16, 2013]

Market Research: MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets ( has announced the addition of the "MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022" report to their offering.

MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more than doubling over this period.

The main drivers of growth will be the dramatic increase in disease prevalence and physicians' efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded drugs.

MK-3102 is a once-weekly oral DPP-4 inhibitor being developed by Merck Sharp & Dohme, and is currently in Phase III clinical trials.

Scope - Overview of type 2 diabetes, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on MK-3102 including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for MK-3102 for the top ten countries from 2012 to 2022.

- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, India and China.

Key Topics Covered: 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Disease Overview 4 Disease Management 5 Competitive Assessment 6 Opportunity and Unmet Need 7 Pipeline Assessment 8 MK-3102 9 Appendix For more information visit About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: Research and Markets, Laura Wood, Senior Manager. Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Pharmaceuticals ( ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to


[ Back To Technology News's Homepage ]


Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2014 Technology Marketing Corporation. All rights reserved.